Literature DB >> 34230972

Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin.

Pragya D Yadav1, Gajanan N Sapkal1, Raches Ella2, Rima R Sahay1, Dimpal A Nyayanit1, Deepak Y Patil1, Gururaj Deshpande1, Anita M Shete1, Nivedita Gupta3, V Krishna Mohan2, Priya Abraham1, Samiran Panda3, Balram Bhargava3.   

Abstract

Entities:  

Keywords:  Beta; Delta; SARS-CoV-2; neutralization; vaccine efficacy

Year:  2021        PMID: 34230972     DOI: 10.1093/jtm/taab104

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


× No keyword cloud information.
  39 in total

Review 1.  An insight into SARS-CoV-2 structure, pathogenesis, target hunting for drug development and vaccine initiatives.

Authors:  Arijit Ghosh; Paritosh K Kar; Anupam Gautam; Rahul Gupta; Rajveer Singh; Rudra Chakravarti; Velayutham Ravichandiran; Shubhra Ghosh Dastidar; Dipanjan Ghosh; Syamal Roy
Journal:  RSC Med Chem       Date:  2022-01-25

Review 2.  Animal models for COVID-19: advances, gaps and perspectives.

Authors:  Changfa Fan; Yong Wu; Xiong Rui; Yuansong Yang; Chen Ling; Susu Liu; Shunan Liu; Youchun Wang
Journal:  Signal Transduct Target Ther       Date:  2022-07-07

Review 3.  COVID-19 vaccines: Update of the vaccines in use and under development.

Authors:  Rafaela Angotti Marta; Gisele Emy Kondo Nakamura; Bruno de Matos Aquino; Paulo R Bignardi
Journal:  Vacunas       Date:  2022-06-22

4.  A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant.

Authors:  Mengxin Zhang; Ying Liang; Dongsheng Yu; Bang Du; Weyland Cheng; Lifeng Li; Zhidan Yu; Shuying Luo; Yaodong Zhang; Huanmin Wang; Xianwei Zhang; Wancun Zhang
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

Review 5.  SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines.

Authors:  Desh Deepak Singh; Amna Parveen; Dharmendra Kumar Yadav
Journal:  Front Cell Infect Microbiol       Date:  2021-12-14       Impact factor: 5.293

6.  SARS-CoV-2 Reinfection Rate and Estimated Effectiveness of the Inactivated Whole Virion Vaccine BBV152 Against Reinfection Among Health Care Workers in New Delhi, India.

Authors:  Sumit Malhotra; Kalaivani Mani; Rakesh Lodha; Sameer Bakhshi; Vijay Prakash Mathur; Pooja Gupta; Saurabh Kedia; Jeeva Sankar; Parmeshwar Kumar; Arvind Kumar; Vineet Ahuja; Subrata Sinha; Randeep Guleria; Aman Dua; Shafi Ahmad; Ramadass Sathiyamoorthy; Ajay Sharma; Tabbu Sakya; Vikas Gaur; Shilpi Chaudhary; Swetambri Sharma; Divya Madan; Anvita Gupta; Shubi Virmani; Arti Gupta; Nidhi Yadav; Surbhi Sachdeva; Shilpi Sharma; Sachin Singh; Abhimanyu Pandey; Mukesh Singh; Divashree Jhurani; Swarnabha Sarkar; Amol Kumar Lokade; Atif Mohammad; Sabitri Pandit; Ritu Dubey; Ajay Kumar Singh; Naveen Gohar; Divyansh Soni; Arunangshu Bhattacharyya; Sabin Rai; Snikitha Tummala; Ishan Gupta; Sakshi Shukla
Journal:  JAMA Netw Open       Date:  2022-01-04

Review 7.  A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues.

Authors:  Shahad Saif Khandker; Brian Godman; Md Irfan Jawad; Bushra Ayat Meghla; Taslima Akter Tisha; Mohib Ullah Khondoker; Md Ahsanul Haq; Jaykaran Charan; Ali Azam Talukder; Nafisa Azmuda; Shahana Sharmin; Mohd Raeed Jamiruddin; Mainul Haque; Nihad Adnan
Journal:  Vaccines (Basel)       Date:  2021-11-24

Review 8.  The biological and clinical significance of emerging SARS-CoV-2 variants.

Authors:  Kaiming Tao; Philip L Tzou; Janin Nouhin; Ravindra K Gupta; Tulio de Oliveira; Sergei L Kosakovsky Pond; Daniela Fera; Robert W Shafer
Journal:  Nat Rev Genet       Date:  2021-09-17       Impact factor: 53.242

9.  Spike protein evolution in the SARS-CoV-2 Delta variant of concern: a case series from Northern Lombardy.

Authors:  Andreina Baj; Federica Novazzi; Francesca Drago Ferrante; Angelo Genoni; Elena Tettamanzi; Giuseppe Catanoso; Daniela Dalla Gasperina; Francesco Dentali; Daniele Focosi; Fabrizio Maggi
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

Review 10.  SARS-CoV-2 Variants, Vaccines, and Host Immunity.

Authors:  Priyal Mistry; Fatima Barmania; Juanita Mellet; Kimberly Peta; Adéle Strydom; Ignatius M Viljoen; William James; Siamon Gordon; Michael S Pepper
Journal:  Front Immunol       Date:  2022-01-03       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.